Literature DB >> 18430722

PDK1 regulates cell proliferation and cell cycle progression through control of cyclin D1 and p27Kip1 expression.

Kyoko Nakamura1, Hiroshi Sakaue, Akihiko Nishizawa, Yasushi Matsuki, Hideyuki Gomi, Eijiro Watanabe, Ryuji Hiramatsua, Mimi Tamamori-Adachi, Shigetaka Kitajima, Tetsuo Noda, Wataru Ogawa, Masato Kasuga.   

Abstract

PDK1 (3-phosphoinositide-dependent protein kinase 1) is a key mediator of signaling by phosphoinositide 3-kinase. To gain insight into the physiological importance of PDK1 in cell proliferation and cell cycle control, we established immortalized mouse embryonic fibroblasts (MEFs) from mice homozygous for a "floxed" allele of Pdk1 and from wild-type mice. Introduction of Cre recombinase by retrovirus-mediated gene transfer resulted in the depletion of PDK1 in Pdk1(lox/lox) MEFs but not in Pdk1(+/+) MEFs. The insulin-like growth factor-1-induced phosphorylation of various downstream effectors of PDK1, including Akt, glycogen synthase kinase 3, ribosomal protein S6, and p70 S6 kinase, was markedly inhibited in the PDK1-depleted (Pdk1-KO) MEFs. The rate of serum-induced cell proliferation was reduced; progression of the cell cycle from the G(0)-G(1) phase to the S phase was delayed, and cell cycle progression at G(2)-M phase was impaired in Pdk1-KO MEFs. These cells also manifested an increased level of p27(Kip1) expression and a reduced level of cyclin D1 expression during cell cycle progression. The defect in cell cycle progression from the G(0)-G(1) to the S phase in Pdk1-KO MEFs was rescued by forced expression of cyclin D1, whereas rescue of the defect in G(2)-M progression in these cells required both overexpression of cyclin D1 and depletion of p27(Kip1) by RNA interference. These data indicate that PDK1 plays an important role in cell proliferation and cell cycle progression by controlling the expression of both cyclin D1 and p27(Kip1).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18430722     DOI: 10.1074/jbc.M802589200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells.

Authors:  Joby J Westmoreland; Qian Wang; Mohamed Bouzaffour; Suzanne J Baker; Beatriz Sosa-Pineda
Journal:  Dev Biol       Date:  2009-07-25       Impact factor: 3.582

2.  Effect of linear alkylbenzene sulfonate (LAS) on human intestinal Caco-2 cells at non cytotoxic concentrations.

Authors:  Mohamed Bradai; Junkyu Han; Abdelfatteh El Omri; Naoyuki Funamizu; Sami Sayadi; Hiroko Isoda
Journal:  Cytotechnology       Date:  2015-05-22       Impact factor: 2.058

3.  OLA1, a Translational Regulator of p21, Maintains Optimal Cell Proliferation Necessary for Developmental Progression.

Authors:  Zonghui Ding; Yue Liu; Valentina Rubio; Jinjie He; Laurie J Minze; Zheng-Zheng Shi
Journal:  Mol Cell Biol       Date:  2016-09-26       Impact factor: 4.272

4.  The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts.

Authors:  Joanna Zabkiewicz; Lorna Pearn; Robert K Hills; Rhys G Morgan; Alex Tonks; Alan K Burnett; Richard L Darley
Journal:  Haematologica       Date:  2013-12-13       Impact factor: 9.941

5.  PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.

Authors:  B K Manne; P Münzer; R Badolia; B Walker-Allgaier; R A Campbell; E Middleton; A S Weyrich; S P Kunapuli; O Borst; M T Rondina
Journal:  J Thromb Haemost       Date:  2018-05-08       Impact factor: 5.824

6.  RFP-mediated ubiquitination of PTEN modulates its effect on AKT activation.

Authors:  James T Lee; Jing Shan; Jiayun Zhong; Muyang Li; Brenda Zhou; Amanda Zhou; Ramon Parsons; Wei Gu
Journal:  Cell Res       Date:  2013-02-19       Impact factor: 25.617

7.  Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages.

Authors:  Bhagirath Chaurasia; Jan Mauer; Linda Koch; Julia Goldau; Anja-Sterner Kock; Jens C Brüning
Journal:  Mol Cell Biol       Date:  2010-06-28       Impact factor: 4.272

8.  Expression of 3-phosphoinositide-dependent protein kinase 1 in colorectal cancer as a potential therapeutic target.

Authors:  Zhenglei Xu; Bihong Liao; Ru Zhang; Jun Yao; Ruiyue Shi; Lisheng Wang
Journal:  Med Oncol       Date:  2015-06-09       Impact factor: 3.064

9.  Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.

Authors:  Lina Zhou; Huifang Dai; Jian Wu; Mian Zhou; Hua Yuan; Juan Du; Lu Yang; Xiwei Wu; Hong Xu; Yuejin Hua; Jian Xu; Li Zheng; Binghui Shen
Journal:  FASEB J       Date:  2016-09-30       Impact factor: 5.191

10.  Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.

Authors:  Tina X Lee; Mark D Packer; Jie Huang; Elena M Akhmametyeva; Samuel K Kulp; Ching-Shih Chen; Marco Giovannini; Abraham Jacob; D Bradley Welling; Long-Sheng Chang
Journal:  Eur J Cancer       Date:  2009-04-07       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.